Free CME from PeerView


Pulmonary/Respiratory Medicine CME

Credits: 0.50 CME
Medical Learning Institute, Inc.
A Visual Exploration of New Opportunities in Thyroid Cancer: Targeting RET Alterations to Optimize Outcomes
December 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Targeting Ocular Toxicity in Multiple Myeloma: Opportunities for Ophthalmology-Oncology Collaboration
December 29, 2020
Credits: 1.50 CME
Penn State College of Medicine
How I Think, How I Treat in the New Age of AML Care: Personal Perspectives on New Evidence and Innovative Therapeutics
December 24, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Rewriting Patient Care in Mantle Cell Lymphoma: How Innovative Therapy Is Poised to Challenge Conventional Treatment
December 24, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Exploring Antibody Therapy in ALL: How and Why to Integrate Antibody-Based Treatment Into Patient Management
December 24, 2020
Credits: 1.50 CME
Penn State College of Medicine
Building New Management Models for NHL Care: Tumor Board Insights on Innovative Therapeutics in FL and DLBCL
December 23, 2020
Credits: 1.50 CME
Penn State College of Medicine
Mapping the New Era in CLL Management: Precision Medicine and Patient Perspectives in Treatment-Naïve and Relapsed Disease
December 23, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Preparing for Personalized Care in Myelodysplastic Syndromes: Integrating Innovative Treatments Into a Cohesive Patient Care Model
December 23, 2020
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Plexiform Neurofibromas: Improving Patient Outcomes With an Innovative Therapeutic Approach
December 18, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Making the Case for Treating Iron Deficiency in Patients With Heart Failure
December 9, 2020
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Personalizing and Prolonging Care in GIST: Expert Guidance on Integrating New TKI Strategies
December 8, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Navigating the Relationship Between Type 2 Inflammation and Uncontrolled, Moderate to Severe Asthma: Identifying Eligible Patients for Targeted Biologic Therapy
December 7, 2020
Credits: 0.50 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Understanding the Relationship Between Type 2 Inflammation, Atopic Diseases, and Treatment Selection: Practical Strategies for the Healthcare Team to Improve Patient Care
December 4, 2020
Credits: 0.50 CME / NCPD / CPE
Penn State College of Medicine / Medical Learning Institute, Inc.
Management of Hyperkalemia in Patients With Hemodialysis-Dependent Chronic Kidney Disease: Applying New Evidence and Best Practices for Improved Patient Outcomes
December 3, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Everything You Need to Know About Molecular Testing and Targeted Therapies in NSCLC: Essential Guidance for Modern Patient-Centered Precision Lung Cancer Care
November 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Improving Recognition and Management of EGPA: A Multidisciplinary Approach to Individualizing Treatment
November 30, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Evolving Treatment Landscape of SSc-ILD: Strategies to Improve Recognition and Management
November 25, 2020
Credits: 1.50 CME / MOC / CNE
PeerView Institute
Emergency Department on Alert: Solving Oncologic Emergency Quandaries During the Immuno-Oncology Era and COVID-19 Pandemic
November 20, 2020
Credits: 1.50 CME / MOC / CNE / CPE
PeerView Institute
Immunotherapy in the Treatment Arsenal for Small Cell Lung Cancer, and Managed Care Implications for the Four Ps: Patient, Provider, Pharmacy, and Plan
November 12, 2020

Pages